Senior insider sale
MADRIGAL PHARMACEUTICALS, INC. — senior position signals high conviction
$22.42M
63.58K shares
What this filing means
TAUB REBECCA plans to sell 63.58K shares of MADRIGAL PHARMACEUTICALS, INC. valued at approximately $22.42M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/11/2025ACC: 0001950047-25-005631
Director
Since Mar 2026
63.58K
Shares to sell
$22.42M
Approx. market value
3.20K
Acquired (3 months)
1
Planned
6 completed
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
8/11/2025
3.20KTotal acquired3.20K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/11/2025 | Exercise of Stock Options Cash | 3.20K | — |
| Total | 3.20K | ||
Planned & Completed Dispositions7
Completed
—Completed
Units to sell
1.40K
Market value
$490.0K
7/18/2025
—Completed
Units to sell
1K
Market value
$350.0K
7/18/2025
—Completed
Units to sell
2.66K
Market value
$931.0K
7/17/2025
—Completed
Units to sell
2.70K
Market value
$946.3K
7/17/2025
—Completed
Units to sell
26.18K
Market value
$9.25M
7/16/2025
—Completed
Units to sell
26.44K
Market value
$9.35M
7/16/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
3.20K
Market value
$1.11M
8/11/2025
Total
Units
63.58K
Value
$22.42M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
7/18/2025 | 1.40K | $490.0K | — | Completed |
7/18/2025 | 1K | $350.0K | — | Completed |
7/17/2025 | 2.66K | $931.0K | — | Completed |
7/17/2025 | 2.70K | $946.3K | — | Completed |
7/16/2025 | 26.18K | $9.25M | — | Completed |
7/16/2025 | 26.44K | $9.35M | — | Completed |
| Planned — Approximate Date | ||||
8/11/2025 | 3.20K | $1.11M | NASDAQ | Planned |
| Total | 63.58K | $22.42M | ||